Abstract
A case is presented of a prepubertal girl with the characteristic somatic features of Albright’s hereditary osteodystrophy, including severe short stature, cataracts and shortening of all metacarpals and metatarsals and of the second middle hand phalanges, whose diagnosis of pseudopseudohypoparathyroidism (PPHP) was confirmed by laboratory evaluation (normocalcemia, normophosphatemia, normal levels of circulating PTH and normal response to exogenous PTH). Since an isolated idiopathic GH deficiency has been diagnosed at the age of 9.7 yr, by an abnormal GH response to standard provocation tests, a poor spontaneous nocturnal GH secretion and a blunted response to GHRH test, our patient was treated with biosynthetic GH during a 3.5-year period. Although a good improvement of growth velocity was obtained when comparing pretreatment height velocity (4 cm/yr) with growth velocity evaluated during GH treatment (6.6, 6.2 and 5.9 cm/yr in the first, the second and the third year of therapy, respectively), bone age advanced more rapidly than chronological age, so that it is uncertain whether the growth acceleration promoted by GH administration really improved final height, which remained below the third centile. Our patient is the first described case of PPHP associated with idiopathic GH deficiency, and the second report of long-term GH treatment in a subject with PPHP. Further observations are necessary to define the frequency and significance of GH deficiency and the role of GH replacement therapy in pseudohypoparathyroidism-and PPHP-associated short stature.
Similar content being viewed by others
References
Fitch N. Albright hereditary osteodystrophy: a review. Am. J. Med. Genet. 11: 11, 1982.
Attanasio R., Giusti M., Lomeo A., Monachesi M., Nalin R., Giordano G. Pseudohypoparathyroidism. An update. Minerva Endocrinol. 12: 19, 1987.
Graudal N., Galloe A., Christensen H., Olesen K. The pattern of shortened hand and foot bones in D-and E-brachydactyly and pseudohypoparathyroidism//pseudopseudohypoparathyroidism. Fortschr. Röntgenstr. 148: 460, 1988.
Levine M.A., Jap T.S., Mauseth R.S., Downs R.W., Spiegel A.M. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright’s hereditary osteodystrophy in six kindreds. J. Clin. Endocrinol. Metab. 62: 497, 1986.
Carlson H.E., Brickman A.S., Bottazzo G.F. Prolactin deficiency in pseudohypoparathyroidism. N. Engl. J. Med. 296: 140, 1977.
Levine M.A., Downs R.W., Moses A.M., Breslau N.A., Marx S.J., Lasker R.D., Rizzoli R.E., Aurbach G.D., Spiegel A.M. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Am. J. Med. 74: 545, 1983.
Marx S.J., Hershman J.M., Aurbach G.D. Thyroid dysfunction in pseudohypoparathyroidism. J. Clin. Endocrinol. 33: 822, 1971.
Shapiro M.S., Bernheim J., Gutman A., Arber I., Spitz I. Multiple abnormalities of anterior pituitary hormones secretion in association with pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 51: 483, 1980.
Wolfsdorf J.I., Rosenfield R.L., Fang V.S., Kobayashi R., Razdan A.K., Kim M.H. Partial gonadotropin resistance in pseudohypoparathyroidism. Acta Endocrinol.(Copenh.) 88: 321, 1978.
Shima M., Nose O., Shimizu K., Scino Y., Yabuuchi H., Saito T. Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a. Eur. J. Pediatr. 147: 536, 1988.
Wagar G., Lehtivuori J., Salven I., Backman R., Sivula A. Pseudohypoparathyroidism associated with hyper-calcitoninemia. Acta Endocrinol. (Copenh.) 93: 43, 1980.
Ridderskamp P., Schlagheche R. Pseudohypoparathyreoidismus und Nebennierenrindeninsuffizienz. Ein Fall von Multipler Endokrinopathie bei peripherer Hormonresistenz. Klin. Wochenschr. 68: 927, 1990.
Staffer S.S. Turner’s syndrome and pseudopseudohypoparathyroidism. J.A.M.A. 247: 1696, 1982.
Kanda T., Nagashima T., Oda M., Hirose K., Tanabe H. Pseudopseudohypoparathyroidism with recurrent polyneuropathy: an autopsy report with special reference to the peripheral nervous system. J. Neurol. Sci. 103: 42, 1991.
Furukawa T. Periodic psychosis associated with pseudo-pseudohypoparathyroidism. J. Nerv. Ment. Dis. 179: 637, 1991.
Reeves R.A., Kiss J.E., Meess M., Levey G.S., Shapiro A.P. Pseudopseudohypoparathyroidism and pheochromocytoma. Association or coincidence? Arch. Intern. Med. 143: 1619, 1983.
Van Dop C., Wang H., Mulaikal R.M., Tolo V.T., Rosenbaum A.E. Pseudopseudohypoparathyroidism with spinal cord compression. Pediatr. Radiol. 18: 429, 1988.
Stirling H.F., Barr D.G.D., Kelnar C.J.H. Familial growth hormone releasing factor deficiency in pseudopseudohypoparathyroidism. Arch. Dis. Child. 66: 533, 1991.
Hanno H.A., Weiss D.L. Hypoparathyroidism, pseudohypoparathyroidism, and pseudopseudohypoparathyroidism. Arch. Ophthalmol. 65: 238, 1961.
Lorette G., Valat J.P., Gatti P., Fetissoff F., Arbeille B., Boistard C., Moraine C. Osteodystrophie héréditaire d’Albright avec osteomes cutanées profus. Ann. Dermatol. Venereol. 111: 1073, 1984.
De Wijn E.M., Steendijk R. Growth and maturation in pseudohypoparathyroidism: a longitudinal study in five patients. Acta Endocrinol.(Copenh.) 101: 223, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manfredi, R., Zucchini, A., Azzaroli, L. et al. Pseudopseudohypoparathyroidism associated with idiopathic Growth Hormone deficiency. Role of treatment with biosynthetic Growth Hormone. J Endocrinol Invest 16, 709–713 (1993). https://doi.org/10.1007/BF03348916
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348916